BX Swiss TOP 30 CHF
1.251,31
PKT
-0,90
PKT
-0,07
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
17.03.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
14.03.25 | Givaudan Add | Baader Bank | |
14.03.25 | Givaudan Hold | Deutsche Bank AG | |
14.03.25 | Givaudan Neutral | UBS AG | |
14.03.25 | Givaudan Underperform | Jefferies & Company Inc. | |
14.03.25 | Richemont Overweight | JP Morgan Chase & Co. | |
13.03.25 | Swiss Re Buy | UBS AG | |
13.03.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
13.03.25 | Roche Hold | Jefferies & Company Inc. | |
12.03.25 | Roche Outperform | Bernstein Research | |
12.03.25 | Roche Buy | UBS AG | |
12.03.25 | Roche Underweight | JP Morgan Chase & Co. | |
12.03.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.03.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
11.03.25 | Givaudan Hold | Deutsche Bank AG | |
10.03.25 | Roche Sell | Deutsche Bank AG | |
10.03.25 | Richemont Outperform | Bernstein Research | |
10.03.25 | UBS Overweight | JP Morgan Chase & Co. | |
06.03.25 | Novartis Buy | Deutsche Bank AG | |
06.03.25 | Richemont Overweight | JP Morgan Chase & Co. | |
05.03.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.03.25 | Swiss Re Sector Perform | RBC Capital Markets | |
03.03.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
03.03.25 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
28.02.25 | Swiss Re Buy | UBS AG | |
28.02.25 | Swiss Re Hold | Deutsche Bank AG | |
28.02.25 | UBS Buy | Deutsche Bank AG | |
27.02.25 | Swiss Re Kaufen | DZ BANK | |
27.02.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
27.02.25 | Swiss Re Sector Perform | RBC Capital Markets | |
27.02.25 | Swiss Re Buy | UBS AG | |
27.02.25 | Swiss Re Hold | Jefferies & Company Inc. | |
27.02.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.02.25 | Swiss Re Overweight | JP Morgan Chase & Co. | |
27.02.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
26.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
25.02.25 | Novartis Neutral | JP Morgan Chase & Co. | |
24.02.25 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
24.02.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
24.02.25 | Zurich Insurance Sell | UBS AG |